Dr. Ugarte-Gil is an Associate Professor at the Department of Epidemiology at SPPH at UTMB. He has PhD in Global Diseases Epidemiology and Control from Johns Hopkins Bloomberg School of Public Health, a MSc in Epidemiology at London School of Hygiene and Tropical Medicine and MD from Universidad Peruana Cayetano Heredia.

Dr. Ugarte-Gil's work is focused on respiratory infections such as Tuberculosis, COVID-19, Influenza and others. His interest is validation of point-of-care diagnostic tools and their implementation at primary care level. Also, he has a specific interest in the association of comorbidities such as diabetes mellitus and depression with tuberculosis, and how this association can affect tuberculosis treatment outcomes. Another interest is research in Bartonella bacilliformis, a bacterial infection common in the Andean region, and other common tropical infections prevalent in Latin America. He has also served as an member of the Expert Board at the National Tuberculosis Program in Peru, independent consultant for PAHO and WHO in Tuberculosis.

• PhD, Global Diseases Epidemiology and Control, The Johns Hopkins University, US, 2017
• MSc Epidemiology, London School of Hygiene and Tropical Medicine, UK, 2009
• MD, Universidad Peruana Cayetano Heredia, Perú , 2005

Research Articles in Peer Reviewed Journals:

Complete list of publications

1. Karlsson L, Öhrnberg I, Sayyab S, Martínez-Enguita D, Gustafsson M, Espinoza P, Méndez-Aranda M, Ugarte-Gil C, Diero L, Tonui R, Paues J, Lerm M. A DNA Methylation Signature from Buccal Swabs to Identify Tuberculosis Infection. J Infect Dis. 2024 Jul 4:jiae333.
2. Faust L, Caceres-Cardenas G, Martinez L, Huddart S, Vidal JR, Corilloclla-Torres R, Ayllon MC, Benedetti A, Pai M, Ugarte-Gil C. Tuberculosis case notifications and outcomes in Peruvian prisons prior to and during the COVID-19 pandemic: a national-level interrupted time series analysis. Lancet Reg Health Am. 2024 Mar 27;33:100723.
3. Palomino-Padilla S, Caceres-Cardenas G, Calderon R, Ko AC, Garnett L, Doan K, Chong P, Lino H, Caceres T, Veres T, Dos Santos CC, Nielsen B, Ugarte-Gil C. Original article: novelty of Canadian manufacture nasopharyngeal swabs for collection of samples being tested for SARS-CoV-2 in a pandemic setting. Front Public Health. 2024 May 9;12:1344295.
4. Schiff HF, Walker NF, Ugarte-Gil C, Tebruegge M, Manousopoulou A, Garbis SD, Mansour S, Wong PHM, Rockett G, Piazza P, Niranjan M, Vallejo AF, Woelk CH, Wilkinson RJ, Tezera LB, Garay-Baquero D, Elkington P. Integrated plasma proteomics identifies tuberculosis-specific diagnostic biomarkers. JCI Insight. 2024 Mar 21;9(8):e173273. doi: 10.1172/jci.insight.173273.
5. Nieto-Gutierrez W, Campos-Chambergo J, Gonzalez-Ayala E, Oyola-Garcia O, Alejandro-Mora A, Luis-Aguirre E, Pasquel-Santillan R, Leiva-Aguirre J, Ugarte-Gil C, Loyola S. Prediction models of COVID-19 fatality in nine Peruvian provinces: A secondary analysis of the national epidemiological surveillance system. PLOS Glob Public Health. 2024 Jan 29;4(1):e0002854. doi: 10.1371/journal.pgph.0002854. eCollection 2024.
6. Koeppel L, Denkinger CM, Wyss R, Broger T, Chegou NN, Dunty JM, Scott K, Cáceres T, Dutoit E, Ugarte-Gil C, Nicol M, Gotuzzo E, Corstjens PLAM, Geluk A, Sutherland J, Sigal GB, Moreau E, Albertini A, Mantsoki A, Ongarello S, Walzl G, Fernandez Suarez M. Diagnostic performance of host protein signatures as a triage test for active pulmonary TB. J Clin Microbiol. 2023 Sep 19;:e0026423. doi: 10.1128/jcm.00264-23.
7. Ruiz-Grosso P, Loret de Mola C, Otero L, Ugarte-Gil C. Are trajectories of depressive symptoms during the first half of drug-sensitive pulmonary tuberculosis treatment associated with loss to follow-up? A secondary analysis of longitudinal data. BMJ Open. 2023 Jul 19;13(7):e068235. doi: 10.1136/bmjopen-2022-068235. PubMed PMID: 37474177;
8. Calderon-Flores R, Caceres-Cardenas G, Alí K, De Vos M, Emperador D, Cáceres T, Eca A, Villa-Castillo L, Albertini A, Sacks JA, Ugarte-Gil C. Diagnostic performance of four lateral flow immunoassays for COVID-19 antibodies in Peruvian population. PLOS Glob Public Health. 2023; 3(6):e0001555.
9. MacLean EL, Villa-Castillo L, Espinoza-Lopez P, Caceres T, Sulis G, Kohli M, Pai M, Ugarte-Gil C. Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a cross-sectional, diagnostic accuracy study. Lancet Microbe. 2023; 4(6):e452-e460.
10. Paredes JL, Picon V, Reynolds L, Ugarte-Gil C, Moore D. Impact of the COVID-19 pandemic on TB care in Peru. Int J Tuberc Lung Dis. 2023; 27(5):411-413.